The Effectiveness of Ruxolitinib for Acute/Chronic Graft-versus-Host Disease in Children: A Retrospective Study

Overview of attention for article published in Drug Design, Development and Therapy, February 2021

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (64th percentile)
High Attention Score compared to outputs of the same age and source (84th percentile)

Mentioned by

news: 1 news outlet

Readers on

mendeley: 27 Mendeley

So far, Altmetric has seen 1 news story.

Ruxolitinib Yielded High Response Rate in Children With Refractory GVHD

Cancer Therapy Advisor, 12 Mar 2021

Additional or replacement treatment with ruxolitinib for acute or chronic graft-vs-host disease (GVHD) resulted in a high…